Skip to main content
Erschienen in: Reactions Weekly 1/2018

01.12.2018 | Case report

Complement-c1-inhibitor protein

Headache: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Excerpt

In a study of 23 patients from November 2015 to July 2017, one patient [age and sex not stated] was described, who developed headache during treatment with complement-c1-inhibitor-protein [C1-INH; Berinert] for hereditary angioedema. …
Literatur
Zurück zum Zitat Dempster J. Practicalities of a reduced volume formulation of a C1-INH concentrate for the treatment of hereditary angioedema: Real-life experience. Allergy, Asthma and Clinical Immunology 14: 44, 25 Oct 2018. Available from: URL: http://doi.org/10.1186/s13223-018-0267-4 - United Kingdom Dempster J. Practicalities of a reduced volume formulation of a C1-INH concentrate for the treatment of hereditary angioedema: Real-life experience. Allergy, Asthma and Clinical Immunology 14: 44, 25 Oct 2018. Available from: URL: http://​doi.​org/​10.​1186/​s13223-018-0267-4 - United Kingdom
Metadaten
Titel
Complement-c1-inhibitor protein
Headache: case report
Publikationsdatum
01.12.2018
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2018
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-018-55002-x

Weitere Artikel der Ausgabe 1/2018

Reactions Weekly 1/2018 Zur Ausgabe

Case report

Erlotinib

Case report

Amlodipine

Case report

Lamotrigine

Case report

Ipilimumab